US Stock MarketDetailed Quotes

CYCN Cyclerion Therapeutics

Watchlist
  • 2.8000
  • -0.3100-9.97%
Trading Feb 19 15:30 ET
7.59MMarket Cap-1.31P/E (TTM)

Cyclerion Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
194K
0
0
0
0
0
0
0
-91.05%297K
0
Operating revenue
--194K
--0
--0
--0
--0
--0
--0
--0
-91.05%297K
--0
Cost of revenue
Gross profit
Operating expense
-51.24%1.32M
-25.79%1.38M
-50.60%1.62M
-48.79%9.65M
-59.71%1.8M
-40.00%2.71M
-86.19%1.87M
-75.21%3.28M
-67.32%18.84M
-69.32%4.46M
Selling and administrative expenses
-41.76%1.24M
-16.19%1.28M
-41.77%1.57M
-36.76%8.13M
-45.99%1.77M
-31.35%2.13M
-56.66%1.53M
-31.60%2.7M
-37.64%12.86M
-25.70%3.28M
-General and administrative expense
-41.76%1.24M
-16.19%1.28M
-41.77%1.57M
-36.76%8.13M
-45.99%1.77M
-31.35%2.13M
-56.66%1.53M
-31.60%2.7M
-37.64%12.86M
-25.70%3.28M
Research and development costs
-86.03%81K
-69.03%105K
-92.31%44K
-74.66%1.52M
-97.96%24K
-58.98%580K
-96.68%339K
-94.13%572K
-84.11%5.98M
-88.76%1.18M
Operating profit
58.39%-1.13M
25.79%-1.38M
50.60%-1.62M
47.97%-9.65M
59.71%-1.8M
40.00%-2.71M
86.12%-1.87M
74.78%-3.28M
65.87%-18.54M
68.93%-4.46M
Net non-operating interest income expense
-60.75%42K
0.00%62K
-13.64%76K
21.77%358K
-23.48%101K
-3.60%107K
37.78%62K
1,366.67%88K
1,937.50%294K
13,300.00%132K
Non-operating interest income
-60.75%42K
0.00%62K
-13.64%76K
21.77%358K
-23.48%101K
-3.60%107K
37.78%62K
--88K
--294K
--132K
Other net income (expense)
110.99%363K
-3.3M
0
-3.3M
Special income (charges)
--0
----
----
---3.3M
--0
---3.3M
----
----
--0
--0
-Less:Impairment of capital assets
--0
----
----
--3.3M
--0
--3.3M
----
----
--0
--0
Other non- operating income (expenses)
--363K
----
----
----
----
----
----
----
----
----
Income before tax
87.76%-723K
26.68%-1.32M
51.62%-1.54M
30.98%-12.59M
60.81%-1.69M
-34.06%-5.91M
86.53%-1.8M
75.44%-3.19M
64.67%-18.25M
59.88%-4.32M
Income tax
Net income
-109.56%-723K
68.38%-1.32M
77.83%-1.54M
88.06%-5.26M
76.52%-1.69M
172.08%7.57M
68.77%-4.18M
46.42%-6.95M
14.66%-44.08M
33.03%-7.22M
Net income continuous Operations
87.76%-723K
26.68%-1.32M
51.62%-1.54M
30.98%-12.59M
60.81%-1.69M
-34.06%-5.91M
86.53%-1.8M
75.44%-3.19M
64.67%-18.25M
59.88%-4.32M
Net income discontinuous operations
--0
--0
--0
128.38%7.33M
--0
321.28%13.47M
---2.38M
---3.77M
---25.83M
---2.89M
Minority interest income
Net income attributable to the parent company
-109.56%-723K
68.38%-1.32M
77.83%-1.54M
88.06%-5.26M
76.52%-1.69M
172.08%7.57M
68.77%-4.18M
46.42%-6.95M
14.66%-44.08M
33.03%-7.22M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-109.56%-723K
68.38%-1.32M
77.83%-1.54M
88.06%-5.26M
76.52%-1.69M
172.08%7.57M
68.77%-4.18M
46.42%-6.95M
14.66%-44.08M
33.03%-7.22M
Basic earnings per share
-109.35%-0.29
71.04%-0.53
80.63%-0.62
88.91%-2.25
78.92%-0.7
164.18%3.1
70.29%-1.83
46.67%-3.2
23.18%-20.28
30.83%-3.32
Diluted earnings per share
-110.66%-0.29
71.04%-0.53
80.63%-0.62
88.91%-2.25
78.92%-0.7
156.31%2.72
70.29%-1.83
46.67%-3.2
23.18%-20.28
30.83%-3.32
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 194K0000000-91.05%297K0
Operating revenue --194K--0--0--0--0--0--0--0-91.05%297K--0
Cost of revenue
Gross profit
Operating expense -51.24%1.32M-25.79%1.38M-50.60%1.62M-48.79%9.65M-59.71%1.8M-40.00%2.71M-86.19%1.87M-75.21%3.28M-67.32%18.84M-69.32%4.46M
Selling and administrative expenses -41.76%1.24M-16.19%1.28M-41.77%1.57M-36.76%8.13M-45.99%1.77M-31.35%2.13M-56.66%1.53M-31.60%2.7M-37.64%12.86M-25.70%3.28M
-General and administrative expense -41.76%1.24M-16.19%1.28M-41.77%1.57M-36.76%8.13M-45.99%1.77M-31.35%2.13M-56.66%1.53M-31.60%2.7M-37.64%12.86M-25.70%3.28M
Research and development costs -86.03%81K-69.03%105K-92.31%44K-74.66%1.52M-97.96%24K-58.98%580K-96.68%339K-94.13%572K-84.11%5.98M-88.76%1.18M
Operating profit 58.39%-1.13M25.79%-1.38M50.60%-1.62M47.97%-9.65M59.71%-1.8M40.00%-2.71M86.12%-1.87M74.78%-3.28M65.87%-18.54M68.93%-4.46M
Net non-operating interest income expense -60.75%42K0.00%62K-13.64%76K21.77%358K-23.48%101K-3.60%107K37.78%62K1,366.67%88K1,937.50%294K13,300.00%132K
Non-operating interest income -60.75%42K0.00%62K-13.64%76K21.77%358K-23.48%101K-3.60%107K37.78%62K--88K--294K--132K
Other net income (expense) 110.99%363K-3.3M0-3.3M
Special income (charges) --0-----------3.3M--0---3.3M----------0--0
-Less:Impairment of capital assets --0----------3.3M--0--3.3M----------0--0
Other non- operating income (expenses) --363K------------------------------------
Income before tax 87.76%-723K26.68%-1.32M51.62%-1.54M30.98%-12.59M60.81%-1.69M-34.06%-5.91M86.53%-1.8M75.44%-3.19M64.67%-18.25M59.88%-4.32M
Income tax
Net income -109.56%-723K68.38%-1.32M77.83%-1.54M88.06%-5.26M76.52%-1.69M172.08%7.57M68.77%-4.18M46.42%-6.95M14.66%-44.08M33.03%-7.22M
Net income continuous Operations 87.76%-723K26.68%-1.32M51.62%-1.54M30.98%-12.59M60.81%-1.69M-34.06%-5.91M86.53%-1.8M75.44%-3.19M64.67%-18.25M59.88%-4.32M
Net income discontinuous operations --0--0--0128.38%7.33M--0321.28%13.47M---2.38M---3.77M---25.83M---2.89M
Minority interest income
Net income attributable to the parent company -109.56%-723K68.38%-1.32M77.83%-1.54M88.06%-5.26M76.52%-1.69M172.08%7.57M68.77%-4.18M46.42%-6.95M14.66%-44.08M33.03%-7.22M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -109.56%-723K68.38%-1.32M77.83%-1.54M88.06%-5.26M76.52%-1.69M172.08%7.57M68.77%-4.18M46.42%-6.95M14.66%-44.08M33.03%-7.22M
Basic earnings per share -109.35%-0.2971.04%-0.5380.63%-0.6288.91%-2.2578.92%-0.7164.18%3.170.29%-1.8346.67%-3.223.18%-20.2830.83%-3.32
Diluted earnings per share -110.66%-0.2971.04%-0.5380.63%-0.6288.91%-2.2578.92%-0.7156.31%2.7270.29%-1.8346.67%-3.223.18%-20.2830.83%-3.32
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
WANDA BEARING
920002
+29.99%
JUNCHUANG TECH
833533
+29.99%
SanFeng Intelligent Equipment Group
300276
+20.04%
4
Dioo Microcircuits
688381
+20.02%
5
Est Tools Co., Ltd.
300488
+20.01%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025